Citadel Advisors’s Cambria Cannabis ETF TOKE Stock Holding History

Citadel Advisors’s Portfolio TOKE Stock Details TOKE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$261K	Buy	51,000 +35,500	+229%	+$203K	﹤0.01%	10797
2025 Q4	$95.5K	Buy	+15,500	New	+$91.9K	﹤0.01%	11679
2025 Q2	–	Sell	-17,100	Closed	-$77K	–	15101
2025 Q1	$77K	Buy	+17,100	New	+$82.9K	﹤0.01%	11808
2024 Q3	–	Sell	-5,000	Closed	-$28.4K	–	15261
2024 Q2	$28.4K	Sell	5,000 -27,500	-85%	-$169K	﹤0.01%	12321
2024 Q1	$209K	Buy	+32,500	New	+$189K	﹤0.01%	10238
2023 Q2	–	Sell	-700	Closed	-$4.37K	–	15249
2023 Q1	$4.37K	Buy	700 +300	+75%	+$2.02K	﹤0.01%	13961
2022 Q4	$2.68K	Buy	+400	New	+$2.88K	﹤0.01%	14300

Other funds holding TOKE

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Citadel Advisors's TOKE Position: Q2 2025 in Review

Citadel Advisors sold out of Cambria Cannabis ETF (TOKE) in Q2 2025, closing a stake of 3,714 shares — an estimated $16.7K sold.

Citadel Advisors first reported a position in TOKE in Q2 2022 and held it in 6 quarters. The position peaked at $213K in Q4 2022. 16 funds tracked by Wall St. Rank hold TOKE as of Q2 2025.

Citadel Advisors reported no remaining Cambria Cannabis ETF position as of Q2 2025 after selling out during the quarter.
Citadel Advisors sold 3,714 Cambria Cannabis ETF shares in Q2 2025, an estimated $16.7K.
Citadel Advisors first reported a position in Cambria Cannabis ETF in Q2 2022 and held it in 6 quarters.
Citadel Advisors's Cambria Cannabis ETF position peaked at $213K in Q4 2022.
16 funds tracked by Wall St. Rank held Cambria Cannabis ETF as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.